Evidence map›Paper›PMID 42796323›Full record

Observational studyMedicina (Kaunas, Lithuania)2026

Clinical Impact of Fingolimod-Associated Lymphopenia in Multiple Sclerosis: A Real-World Cohort Study.

Murat Yeniçeri, Mustafa Can Şenoymak, Süleyman Baş, Hasan Hakan Çoban, Ayşe Gürbüz Yeniçeri, Serkan Demir, Alpaslan Tanoglu

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Murat YeniçeriDepartment of Rheumatology, University of Health Sciences, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul 34865, Türkiye.
Mustafa Can ŞenoymakDepartment of Endocrinology, University of Health Sciences, Sultan 2. Abdulhamid Han Training and Research Hospital, Istanbul 34668, Türkiye.
Süleyman BaşDepartment of Internal Medicine, University of Health Sciences, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul 34785, Türkiye.ORCID 0000-0002-5883-445X
Hasan Hakan ÇobanDepartment of Internal Medicine, University of Health Sciences, Eskişehir City Hospital, Eskişehir 26080, Türkiye.ORCID 0000-0001-6978-8332
Ayşe Gürbüz YeniçeriDepartment of Neurology, Sultanbeyli State Hospital, Istanbul 34935, Türkiye.ORCID 0000-0003-3015-1849
Serkan DemirDepartment of Neurology, University of Health Sciences, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul 34785, Türkiye.
Alpaslan TanogluDepartment of Internal Medicine, Bahçeşehir University, Göztepe Medical Park Hospital, Istanbul 34865, Türkiye.ORCID 0000-0002-7477-6640

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fingolimod HydrochlorideImmunosuppressive AgentsLymphopeniaMultiple SclerosisAdultCohort StudiesFemaleHumansLogistic ModelsLymphocyte CountMaleMiddle AgedRetrospective StudiesFingolimod HydrochlorideImmunosuppressive Agentsfingolimodhematological changesinfectionslymphopeniamultiple sclerosis

Identifiers

PMID42796323
PMCPMC13609099

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.